SCHEMBL11025698

SCHEMBL11025698

CN1CCN(CCCOC(=O)CCl)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 7/20 0.47
DRD3 P35462 2/20 0.47
PAOX Q6QHF9 1/20 0.46
RAB9A P51151 2/20 0.43
SLC29A1 Q99808 2/20 0.41
NPC1 O15118 1/20 0.41
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 1/20 0.40
USP2 O75604 1/20 0.40
HPGD P15428 1/20 0.40
HRH2 P25021 2/20 0.39
HRH1 P35367 2/20 0.39
SIGMAR1 Q99720 1/20 0.39
TLR7 Q9NYK1 1/20 0.39
MEN1 O00255 1/20 0.39
ABCC4 O15439 1/20 0.39
LMNA P02545 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11027681 0.89 ALDH1A1 (0.47) HRH3DRD3PAOXRAB9ASLC29A1
SCHEMBL11023279 0.86 CYP2D6 (0.49) HRH3RAB9ANPC1ALDH1A1KDM4E
SCHEMBL13265451 0.84 NAAA (0.48) HRH3DRD3PAOXRAB9ASLC29A1
SCHEMBL11023682 0.84 CYP2D6 (0.51) HRH3ALDH1A1KDM4EMEN1CYP2D6
SCHEMBL562204 0.83 HRH3 (0.47) HRH3DRD3PAOXRAB9ASLC29A1
SCHEMBL1301323 0.82 HRH3 (0.49) HRH3DRD3PAOXRAB9ASLC29A1
SCHEMBL11024196 0.81 KDM4E (0.50) HRH3ALDH1A1KDM4EUSP2HPGD
Hydrochloric Acid SCHEMBL1950623 0.81 HRH3 (0.48) HRH3DRD3PAOXRAB9ASLC29A1
SCHEMBL16845085 0.80 HRH3 (0.50) HRH3DRD3PAOXRAB9ASLC29A1
SCHEMBL11026771 0.79 MEN1 (0.51) HRH3MEN1CYP2D6MAPK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0040793-B1 NOVEL QUINAZOLINE-DIONE COMPOUNDS, PROCESS FOR PRODUCTION THEREOF AND PHARMACEUTICAL USE THEREOF Ishikawa, Masayuki (JP) 1985-08-28 EP disclosed